StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
377220.KQ$717.00-3.11%
Fair $717.00+0.0%

377220.KQ

From Bio Co.,Ltd

Consumer Defensive / Packaged FoodsKOSDAQ

$717.00

-23.00 (-3.11%)

Fairly Valued+0.0%Fair Value $717.00Fund rank 25/100 · Data gapFallback financials|
SA 5/F
F-Score: 4/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 19%

FCF escenarios

weak_data · normalized FCF $-16.3B · quality 48.0/100

Data gap 25/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 31/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

5/100

F

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -80.1%, below the 5% threshold
Thesis & Journal · 377220.KQLocal privado en este navegador · From Bio Co.,Ltd
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$20.3B

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-80.1%

↓

Gross Margin

57.6%

↑

Debt/Equity

1.26

↑
52-Week Range$717
$709$3785

TradingView lightweight chart

377220.KQ price, volumen y niveles de valoración

Último $717.00Periodo -96.4%
Fair value: $717.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-10.1%

FCF CAGR

—

FCF margin

-15.7%

FCF / Net income

0.50x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $72.16B · net income $-22.46B · FCF $-11.34B

2022-FY → 2025-FY

Gross margin

57.6%-12.2% pts

Operating margin

-25.8%-26.7% pts

Net margin

-31.1%-34.4% pts

FCF margin

-15.7%+1.6% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$72.16B$72.16B$67.18B$66.72B$99.33B
Net Income$-22.46B$-22.46B$-25.29B$-11.08B$3.24B
EBITDA$-17.41B$-17.41B$-21.58B$-13.91B$2.67B
EPS-793.00-793.00-893.00-195.5057.00
Gross Margin57.6%57.6%55.3%68.9%69.8%
Operating Margin-25.8%-25.8%-36.1%-23.1%0.9%
Net Margin-31.1%-31.1%-37.6%-16.6%3.3%
Balance Sheet
Debt/Equity1.261.260.530.240.01
Current Ratio0.400.40———
Cash Flow
Free Cash Flow$-11.34B$-11.34B$-16.27B$-37.54B$-17.21B
Returns
ROE-80.1%-80.1%-50.3%-14.5%3.7%
Valuation
P/E————165.44
EV/EBITDA————99.52
P/B0.720.721.134.663.03
Growth & Yield
Revenue Growth7.4%7.4%0.7%-32.8%—
EPS Growth11.2%11.2%-356.8%-443.0%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -76.1%

Total return

-76.1%

Start / end P/E

n/dx → n/dx

EPS bridge

-893.00 → -793.00

Residual

-76.1%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-76.1%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.